NRXS vs. HYPR, VANI, ECOR, POCI, MOVE, IRIX, CUTR, PXDT, STRR, and QTI
Should you be buying NeurAxis stock or one of its competitors? The main competitors of NeurAxis include Hyperfine (HYPR), Vivani Medical (VANI), electroCore (ECOR), Precision Optics (POCI), Movano (MOVE), IRIDEX (IRIX), Cutera (CUTR), Pixie Dust Technologies (PXDT), Star Equity (STRR), and QT Imaging (QTI). These companies are all part of the "electromedical equipment" industry.
NeurAxis (NASDAQ:NRXS) and Hyperfine (NASDAQ:HYPR) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their media sentiment, dividends, analyst recommendations, earnings, institutional ownership, profitability, community ranking, valuation and risk.
11.8% of NeurAxis shares are held by institutional investors. Comparatively, 15.0% of Hyperfine shares are held by institutional investors. 15.2% of NeurAxis shares are held by insiders. Comparatively, 29.4% of Hyperfine shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
In the previous week, Hyperfine had 2 more articles in the media than NeurAxis. MarketBeat recorded 2 mentions for Hyperfine and 0 mentions for NeurAxis. Hyperfine's average media sentiment score of 0.22 beat NeurAxis' score of 0.00 indicating that Hyperfine is being referred to more favorably in the news media.
Hyperfine received 3 more outperform votes than NeurAxis when rated by MarketBeat users. However, 100.00% of users gave NeurAxis an outperform vote while only 44.44% of users gave Hyperfine an outperform vote.
Hyperfine has a net margin of -358.59% compared to NeurAxis' net margin of -633.10%. NeurAxis' return on equity of 0.00% beat Hyperfine's return on equity.
NeurAxis has higher earnings, but lower revenue than Hyperfine. Hyperfine is trading at a lower price-to-earnings ratio than NeurAxis, indicating that it is currently the more affordable of the two stocks.
Hyperfine has a consensus target price of $2.12, suggesting a potential upside of 82.47%. Given Hyperfine's higher possible upside, analysts plainly believe Hyperfine is more favorable than NeurAxis.
Summary
Hyperfine beats NeurAxis on 10 of the 16 factors compared between the two stocks.
Get NeurAxis News Delivered to You Automatically
Sign up to receive the latest news and ratings for NRXS and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding NRXS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
NeurAxis Competitors List
Related Companies and Tools
Free NRXS Stock Alerts